Mutations in TP53, RUNX1, ASXL1, SRSF2, IDH2, BCOR, STAG2, and NUP98 have been described as poor prognostic markers in concomitant SF3B1 mutated MDS. The gene discussed is SRSF2; the disease is myelodysplastic syndrome.